Pneumoconiosis laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(10 intermediate revisions by the same user not shown)
Line 2: Line 2:
{{Pneumoconiosis}}
{{Pneumoconiosis}}
{{CMG}}; {{AE}} [[User:Dushka|Dushka Riaz, MD]]
{{CMG}}; {{AE}} [[User:Dushka|Dushka Riaz, MD]]
==Overview==
There are no diagnostic laboratory findings associated with [[pneumoconiosis]]. Findings are generally nonspecific and therefore not of clinical significance. [[Rheumatoid factor]] and [[ESR]] may be present, but do not indicate [[disease]] activity or severity. <ref name="pmid4918296">{{cite journal| author=Turner-Warwick M, Parkes WR| title=Circulating rheumatoid and antinuclear factors in asbestos workers. | journal=Br Med J | year= 1970 | volume= 3 | issue= 5721 | pages= 492-5 | pmid=4918296 | doi=10.1136/bmj.3.5721.492 | pmc=1701367 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4918296  }} </ref>
==Laboratory Findings==
There are no diagnostic laboratory findings associated with [[pneumoconiosis]]. A screening blood [[beryllium]] [[lymphocyte]] proliferation test can be used for those patients with suspected [[berylliosis]]. Patients may also undergo a [[tuberculin skin test]] to exclude [[tuberculosis]]. Some patients with [[pneumoconiosis]] may have elevated concentrations of some serum and urinary markers. These include SMRP and fibulin-3, which suggest [[asbestos]] exposure. Research is also in the development of a breath test to test for [[pneumoconiosis]] which would check the levels of [[pentane]], C5-C7 [[Alkane|alkanes]], and methylated alkanes. <ref name="pmid32310362">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume=  | issue=  | pages=  | pmid=32310362 | doi= | pmc= | url= }} </ref> <ref name="pmid30955520">{{cite journal| author=Perlman DM, Maier LA| title=Occupational Lung Disease. | journal=Med Clin North Am | year= 2019 | volume= 103 | issue= 3 | pages= 535-548 | pmid=30955520 | doi=10.1016/j.mcna.2018.12.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30955520  }} </ref> <ref name="pmid30946771">{{cite journal| author=Yang HY| title=Prediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals. | journal=PLoS One | year= 2019 | volume= 14 | issue= 4 | pages= e0214808 | pmid=30946771 | doi=10.1371/journal.pone.0214808 | pmc=6448873 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30946771  }} </ref> <ref name="pmid25398119">{{cite journal| author=Balmes JR, Abraham JL, Dweik RA, Fireman E, Fontenot AP, Maier LA | display-authors=etal| title=An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. | journal=Am J Respir Crit Care Med | year= 2014 | volume= 190 | issue= 10 | pages= e34-59 | pmid=25398119 | doi=10.1164/rccm.201409-1722ST | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25398119  }} </ref>


==References==
==References==

Latest revision as of 23:05, 26 April 2021

Pneumoconiosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumoconiosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumoconiosis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumoconiosis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumoconiosis laboratory findings

CDC on Pneumoconiosis laboratory findings

Pneumoconiosis laboratory findings in the news

Blogs on Pneumoconiosis laboratory findings

Directions to Hospitals Treating Pneumoconiosis

Risk calculators and risk factors for Pneumoconiosis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD

Overview

There are no diagnostic laboratory findings associated with pneumoconiosis. Findings are generally nonspecific and therefore not of clinical significance. Rheumatoid factor and ESR may be present, but do not indicate disease activity or severity. [1]

Laboratory Findings

There are no diagnostic laboratory findings associated with pneumoconiosis. A screening blood beryllium lymphocyte proliferation test can be used for those patients with suspected berylliosis. Patients may also undergo a tuberculin skin test to exclude tuberculosis. Some patients with pneumoconiosis may have elevated concentrations of some serum and urinary markers. These include SMRP and fibulin-3, which suggest asbestos exposure. Research is also in the development of a breath test to test for pneumoconiosis which would check the levels of pentane, C5-C7 alkanes, and methylated alkanes. [2] [3] [4] [5]

References

  1. Turner-Warwick M, Parkes WR (1970). "Circulating rheumatoid and antinuclear factors in asbestos workers". Br Med J. 3 (5721): 492–5. doi:10.1136/bmj.3.5721.492. PMC 1701367. PMID 4918296.
  2. "StatPearls". 2021. PMID 32310362 Check |pmid= value (help).
  3. Perlman DM, Maier LA (2019). "Occupational Lung Disease". Med Clin North Am. 103 (3): 535–548. doi:10.1016/j.mcna.2018.12.012. PMID 30955520.
  4. Yang HY (2019). "Prediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals". PLoS One. 14 (4): e0214808. doi:10.1371/journal.pone.0214808. PMC 6448873. PMID 30946771.
  5. Balmes JR, Abraham JL, Dweik RA, Fireman E, Fontenot AP, Maier LA; et al. (2014). "An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease". Am J Respir Crit Care Med. 190 (10): e34–59. doi:10.1164/rccm.201409-1722ST. PMID 25398119.

Template:WH Template:WS